{"schema_version":"1","generated_at":"2026-11-14T06:39:32.080Z","data_as_of":null,"url":"https://www.findmykol.com/kol/don-gibbons","json_url":"https://www.findmykol.com/kol/don-gibbons/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"don-gibbons","name":"Don Gibbons","credential":"MD, PhD","specialty":"Internal Medicine","specialty_raw":"Internal Medicine","therapeutic_area":"Primary Care","therapeutic_areas":["Primary Care"],"institution":"The University of Texas MD Anderson Cancer Center","institution_url":"https://www.findmykol.com/institution/the-university-of-texas-md-anderson-cancer-center","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1700064771","orcid":"0000-0003-2362-3094","openalex":"A5010884206"},"summary":"Don Gibbons is a Primary Care physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 521 publications with 24,520 citations (h-index 84); ClinicalTrials.gov lists 4 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Internal Medicine profiles in the FindMyKOL directory.","overview":null,"focus":{"indications":[],"research_topics":["Primary Care"]},"scholarship":{"works_count":521,"cited_by_count":24520,"h_index":84,"latest_activity_year":2024,"citation_standing":{"top_percent":5,"cohort":"Internal Medicine","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":4,"shown":3,"withheld":1,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03581487","title":"Durvalumab, Tremelimumab, and Selumetinib in Treating Participants With Recurrent or Stage IV Non-small Cell Lung Cancer","phase":"PHASE1/PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"M.D. Anderson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT03581487","trial_url":"https://www.findmykol.com/trial/NCT03581487"},{"nct":"NCT03004105","title":"MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)","phase":"PHASE2","status":"WITHDRAWN","role":"Overall official","sponsor":"M.D. Anderson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT03004105","trial_url":"https://www.findmykol.com/trial/NCT03004105"},{"nct":"NCT02088112","title":"MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC).","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"MedImmune LLC","source_url":"https://clinicaltrials.gov/study/NCT02088112","trial_url":"https://www.findmykol.com/trial/NCT02088112"}],"source":"trials"},"funding":{"award_count":4,"fiscal_years":{"first":2010,"last":2024},"rows_total":17,"shown":3,"withheld":14,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R37CA214609","title":"The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer","fiscal_year":2024,"amount_usd":"352047","organization":"UNIVERSITY OF TX MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R37CA214609"},{"project":"P50CA070907","title":"Project 3: Targeting Vulnerabilities in the Fibrotic Extracellular Matrix (ECM) of Lung Cancers","fiscal_year":2024,"amount_usd":"240614","organization":"UT SOUTHWESTERN MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/P50CA070907"},{"project":"R37CA214609","title":"The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer","fiscal_year":2023,"amount_usd":"363165","organization":"UNIVERSITY OF TX MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R37CA214609"}],"source":"grants"},"similar":[{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Anil Sood","slug":"anil-sood","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/anil-sood","json_url":"https://www.findmykol.com/kol/anil-sood/profile.json"},{"name":"Jaffer Ajani","slug":"jaffer-ajani","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jaffer-ajani","json_url":"https://www.findmykol.com/kol/jaffer-ajani/profile.json"},{"name":"Michael Matthay","slug":"michael-matthay","institution":"University of California San Francisco","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/michael-matthay","json_url":"https://www.findmykol.com/kol/michael-matthay/profile.json"},{"name":"Elaine Hylek","slug":"elaine-hylek","institution":"Boston University Chobanian and Avedisian School of Medicine","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/elaine-hylek","json_url":"https://www.findmykol.com/kol/elaine-hylek/profile.json"},{"name":"Wilbert Aronow","slug":"wilbert-aronow","institution":"Westchester Medical Center","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/wilbert-aronow","json_url":"https://www.findmykol.com/kol/wilbert-aronow/profile.json"},{"name":"David Mannino","slug":"david-mannino","institution":"University of Kentucky","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/david-mannino","json_url":"https://www.findmykol.com/kol/david-mannino/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"funding":14}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}